Provention Bio Inc $ 15.00 -0.5 (-3.23%)
Volume:
2,517,586
Avg Vol (1m):
785,329
Market Cap $:
847.32 Mil
Enterprise Value $:
700.16 Mil
P/E (TTM):
0.00
P/B:
6.24
Financial Strength | 7/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | No Debt | ||
Interest Coverage | No Debt | ||
Piotroski F-Score | 2 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -70.36 | ||
ROA % | -65.08 | ||
ROC (Joel Greenblatt) % | -22144.89 |
PRVB
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 6.24 | ||
EV-to-EBIT | -8.98 | ||
EV-to-EBITDA | -8.98 | ||
Current Ratio | 9.23 | ||
Quick Ratio | 9.23 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 6.25 | ||
Earnings Yield (Greenblatt) % | -11.14 |